Cardiac electrophysiology

Global ECG Equipment & Management System Market Analysis by Type & Region (2014-2025) - ResearchAndMarkets.com

Retrieved on: 
Friday, August 2, 2019

The "ECG Equipment & Management System Market Analysis By Type (Holter Monitors, Resting ECG System, Stress ECG Monitors, Event Monitoring Systems, ECG Management System), By Region, And Segment Forecasts, 2014 - 2025" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "ECG Equipment & Management System Market Analysis By Type (Holter Monitors, Resting ECG System, Stress ECG Monitors, Event Monitoring Systems, ECG Management System), By Region, And Segment Forecasts, 2014 - 2025" report has been added to ResearchAndMarkets.com's offering.
  • The global ECG equipment and management market is expected to reach USD 7.63 million by 2025.
  • Furthermore, increase in investment by various market players and government agencies for development and commercialization of various sensitive and easy-to-use equipment is likely to drive market growth.
  • Geographically, North America was the major contributor in the ECG equipment and management market in 2016.

Global Electrocardiography Devices (ECG) Market 2019-2023 | Emergence of Handheld, Wireless, and Remote Monitoring ECG Devices to Boost Growth | Technavio

Retrieved on: 
Thursday, August 1, 2019
Key Points: 
  • View the full release here: https://www.businesswire.com/news/home/20190801005369/en/
    Technavio has announced its latest market research report titled global electrocardiography devices (ECG) market 2019-2023.
  • This global electrocardiography devices (ECG) market 2019-2023 research report also analyzes other important trends and market drivers that will affect market growth over 2019-2023.
  • Global Electrocardiography Devices (ECG) Market: Segmentation Analysis
    This market research report segments the global electrocardiography devices (ECG) market by product (resting ECG devices, ambulatory ECG monitoring devices, and stress ECG test devices) and geographical regions (North America, Europe, Asia, and ROW).
  • The resting ECG devices segment led the market in 2018, followed by ambulatory ECG monitoring devices, and stress ECG test devices respectively.

Global $2.7 Bn Ventricular Assist Devices and Total Artificial Heart Market 2019-2023: Focus on Products, Distribution Channels, Regional, Data - ResearchAndMarkets.com

Retrieved on: 
Thursday, August 1, 2019

What are the major market drivers, challenges, and opportunities in the global ventricular assist devices and artificial heart systems?

Key Points: 
  • What are the major market drivers, challenges, and opportunities in the global ventricular assist devices and artificial heart systems?
  • What are the leading companies dominating the global ventricular assist devices and artificial heart systems market?
  • What are investors' perceptions about the global ventricular assist devices and artificial heart systems market?
  • What was the market value of the leading segments and sub-segments of the global ventricular assist devices and artificial heart systems market?

Prix Galien Selects BIOTRONIK's PK Papyrus Covered Coronary Stent as Award Finalist

Retrieved on: 
Wednesday, July 31, 2019

LAKE OSWEGO, Ore., July 31, 2019 /PRNewswire/ -- BIOTRONIK today announced the company's PK Papyrus covered coronary stent system1 has been named a finalist in the 2019 Prix Galien USA Awards Ceremony for Best Medical Technology.

Key Points: 
  • LAKE OSWEGO, Ore., July 31, 2019 /PRNewswire/ -- BIOTRONIK today announced the company's PK Papyrus covered coronary stent system1 has been named a finalist in the 2019 Prix Galien USA Awards Ceremony for Best Medical Technology.
  • PK Papyrus is used in emergency situations to create a physical barrier to seal life-threatening perforated coronary arteries without the need for invasive surgery.
  • In September 2018, BIOTRONIK's covered stent was named the first FDA-approved device for the treatment of coronary artery perforation in nearly two decades.
  • Award winners will be announced during the October 24 Prix Galien USA Awards Ceremony in New York City.

PhysIQ Inc. Receives FDA Clearance of Continuous Ambulatory Respiration Rate Algorithm Enabling Artificial Intelligence-based Analytics for Biopharma Companies and Payers

Retrieved on: 
Wednesday, July 31, 2019

PhysIQ, a leader in applying artificial intelligence to wearable sensor data, today announced that it has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for their algorithm to continuously determine respiration rate in ambulatory patients.

Key Points: 
  • PhysIQ, a leader in applying artificial intelligence to wearable sensor data, today announced that it has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for their algorithm to continuously determine respiration rate in ambulatory patients.
  • This clearance adds to their expanding portfolio of FDA-cleared cloud-based analytics, which also include QRS detection, heart rate, heart rate variability, atrial fibrillation detection, and their personalized physiology change detection analytic.
  • We are encouraged by the successful clearance of respiration as a core dimension of human cardiopulmonary physiology which will accelerate our development of further AI analytics.
  • PhysIQ is a company dedicated to enabling proactive care delivery models through pinpointIQ, its highly scalable cloud-based platform for personalized physiology analytics.

The global ventricular assist devices and artificial heart systems market was estimated at $2.20 billion in 2018 and is anticipated to reach $2.70 billion by 2023

Retrieved on: 
Wednesday, July 31, 2019

What are the major market drivers, challenges, and opportunities in the global ventricular assist devices and artificial heart systems?

Key Points: 
  • What are the major market drivers, challenges, and opportunities in the global ventricular assist devices and artificial heart systems?
  • What are the leading companies dominating the global ventricular assist devices and artificial heart systems market?
  • What was the market value of the leading segments and sub-segments of the global ventricular assist devices and artificial heart systems market?
  • Global Ventricular Assist Devices and Artificial Heart Systems Market Forecast, 2019-2023
    The global ventricular assist devices and artificial heart systems market was estimated at $2.20 billion in 2018 and is anticipated to reach $2.70 billion by 2023.

SentreHEART Announces Initial Clinical Use of the LARIAT® with EpiRAIL™ Procedure for Left Atrial Appendage Exclusion

Retrieved on: 
Tuesday, July 30, 2019

The LARIAT with EpiRAIL is an epicardial-only, percutaneous approach to complete and permanent closure of the left atrial appendage (LAA) in patients with atrial fibrillation and increased risk of stroke.

Key Points: 
  • The LARIAT with EpiRAIL is an epicardial-only, percutaneous approach to complete and permanent closure of the left atrial appendage (LAA) in patients with atrial fibrillation and increased risk of stroke.
  • The LARIAT with EpiRAIL eliminates the requirement of a transseptal catheterization in order to enter the left atrium of the heart.
  • Founded in 2005, SentreHEART has developed innovative technology for remote delivery of suture for closure of anatomic structures including the left atrial appendage.
  • Percutaneous Left Atrial Appendage Suture Ligation Using the LARIAT Device in Patients with Atrial Fibrillation.

Major Players Operating in the Global Cardiology Electrodes Market from 2019-2023 | Technavio

Retrieved on: 
Friday, July 26, 2019

Furthermore, the industry research report also presents a competitive analysis of the market by product (resting ECG electrodes, short-term monitoring ECG electrodes, long-term monitoring ECG electrodes, stress test ECG electrodes, and neonatal ECG electrodes) and geography (Asia, Europe, North America, and ROW).

Key Points: 
  • Furthermore, the industry research report also presents a competitive analysis of the market by product (resting ECG electrodes, short-term monitoring ECG electrodes, long-term monitoring ECG electrodes, stress test ECG electrodes, and neonatal ECG electrodes) and geography (Asia, Europe, North America, and ROW).
  • View the full release here: https://www.businesswire.com/news/home/20190726005128/en/
    Technavio has announced its latest market research report titled global cardiology electrodes market 2019-2023.
  • The companys key offerings include: Kendall 5400 Tab Electrodes, Kendall Repositionable Cloth Series Electrodes, Kendall AC30 Cloth Series Electrodes, Kendall SF450 Series Electrodes, Kendall 700 Series Tape Electrodes, and Kendall Clear Tape Pre-wired Electrodes.
  • The companys key offerings include: Cleartrace electrodes, Omnitrace electrodes, Softrace Cloth Electrodes, Cleartrode Electrodes, Fastrace 4, and HeartBeat.

Giant Food Announces the Addition of Automated External Defibrillators (AEDs) to All Stores

Retrieved on: 
Tuesday, July 23, 2019

LANDOVER, Md., July 23, 2019 /PRNewswire/ -- Giant Food, the leading greater Washington D.C. regional grocery chain, announces today that it has installed public access automated external defibrillators (AEDs) in all of its 164 stores across Washington, D.C., Maryland, Virginia and Delaware.

Key Points: 
  • LANDOVER, Md., July 23, 2019 /PRNewswire/ -- Giant Food, the leading greater Washington D.C. regional grocery chain, announces today that it has installed public access automated external defibrillators (AEDs) in all of its 164 stores across Washington, D.C., Maryland, Virginia and Delaware.
  • The AEDs were placed in the closest proximity to the front and middle of all stores as of June 30th, 2019.
  • The addition of the AEDs comes as part of Giant's ongoing efforts to further support the local communities by taking care of its neighbors and supporting healthy lives.
  • Giant Food is headquartered inLandover, Md.and operates 164 supermarkets inVirginia,Maryland,Delaware, and theDistrict of Columbia.

Outlook on the World Cardiac Monitoring Market to 2024 - ECG Monitor Projected to Dominate

Retrieved on: 
Thursday, July 18, 2019

DUBLIN, July 18, 2019 /PRNewswire/ -- The "Global Cardiac Monitoring Market - Growth, Trends, and Forecast (2019 - 2024)" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • DUBLIN, July 18, 2019 /PRNewswire/ -- The "Global Cardiac Monitoring Market - Growth, Trends, and Forecast (2019 - 2024)" report has been added to ResearchAndMarkets.com's offering.
  • Furthermore, cardiac monitoring is one of the most reliable and efficient options for the monitoring of various cardiac conditions.
  • However, rising incidences of infection, high cost associated with the monitoring and stringent regulatory procedures may act as restraints for the growth of global cardiac monitoring market over the forecast period.
  • There are two different types of ECG monitors available in the market such as Monitoring ECG Systems and Diagnostic ECG Systems.